Chief Development Officer, Dr Nicholas Boyd
Cell therapies have the potential to not only be life-saving but curative for a host of diseases. However, inherent limitations in autologous based CAR-T therapy face major roadblocks for mass adoption and therapeutic effects in solid tumour indications.
On Friday 28 January at 7:30 am AEDT Nicholas will discuss the design, manufacture and translation of cell therapies in a presentation entitled Advancing Off-The-Shelf Immunotherapy for Solid Tumours: Using Gene-Edited iNK Cells.
Download the program: Home | 2nd Multi-Functional Cell Therapies Digital Summit | January 25-27 (multi-functional-cell-therapies.com)